EMEA (Europe, Middle East and Africa) Oligonucleotide Synthesis Market Report 2017
- QYR1537503
- 114 Pages
- September 2017
- Energy and Power
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Oligonucleotide Synthesis for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Oligonucleotide Synthesis market competition by top manufacturers/players, with Oligonucleotide Synthesis sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Genescript
GeneArt (Thermofischer)
IDT
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Primers
Probes
Intermediate-scale Synthesis Oligos
Large-scale Synthesis Oligos
Linkers and Adaptors
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Oligonucleotide Synthesis for each application, including
Commercial
Academic Research
EMEA (Europe, Middle East and Africa) Oligonucleotide Synthesis Market Report 2017
1 Oligonucleotide Synthesis Overview
1.1 Product Overview and Scope of Oligonucleotide Synthesis
1.2 Classification of Oligonucleotide Synthesis
1.2.1 EMEA Oligonucleotide Synthesis Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Oligonucleotide Synthesis Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Primers
1.2.4 Probes
1.2.5 Intermediate-scale Synthesis Oligos
1.2.6 Large-scale Synthesis Oligos
1.2.7 Linkers and Adaptors
1.3 EMEA Oligonucleotide Synthesis Market by Application/End Users
1.3.1 EMEA Oligonucleotide Synthesis Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Commercial
1.3.3 Academic Research
1.4 EMEA Oligonucleotide Synthesis Market by Region
1.4.1 EMEA Oligonucleotide Synthesis Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Oligonucleotide Synthesis (2012-2022)
1.5.1 EMEA Oligonucleotide Synthesis Sales and Growth Rate (2012-2022)
1.5.2 EMEA Oligonucleotide Synthesis Revenue and Growth Rate (2012-2022)
2 EMEA Oligonucleotide Synthesis Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Oligonucleotide Synthesis Market Competition by Players/Manufacturers
2.1.1 EMEA Oligonucleotide Synthesis Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Oligonucleotide Synthesis Revenue and Share by Players (2012-2017)
2.1.3 EMEA Oligonucleotide Synthesis Sale Price by Players (2012-2017)
2.2 EMEA Oligonucleotide Synthesis (Volume and Value) by Type/Product Category
2.2.1 EMEA Oligonucleotide Synthesis Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Oligonucleotide Synthesis Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Oligonucleotide Synthesis Sale Price by Type (2012-2017)
2.3 EMEA Oligonucleotide Synthesis (Volume) by Application
2.4 EMEA Oligonucleotide Synthesis (Volume and Value) by Region
2.4.1 EMEA Oligonucleotide Synthesis Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Oligonucleotide Synthesis Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Oligonucleotide Synthesis Sales Price by Region (2012-2017)
3 Europe Oligonucleotide Synthesis (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Oligonucleotide Synthesis Sales and Value (2012-2017)
3.1.1 Europe Oligonucleotide Synthesis Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Oligonucleotide Synthesis Revenue and Growth Rate (2012-2017)
3.2 Europe Oligonucleotide Synthesis Sales and Market Share by Type
3.3 Europe Oligonucleotide Synthesis Sales and Market Share by Application
3.4 Europe Oligonucleotide Synthesis Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Oligonucleotide Synthesis Sales Volume by Countries (2012-2017)
3.4.2 Europe Oligonucleotide Synthesis Revenue by Countries (2012-2017)
3.4.3 Germany Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
3.4.4 France Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
3.4.5 UK Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
3.4.6 Russia Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
3.4.7 Italy Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
3.4.8 Benelux Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
4 Middle East Oligonucleotide Synthesis (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Oligonucleotide Synthesis Sales and Value (2012-2017)
4.1.1 Middle East Oligonucleotide Synthesis Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Oligonucleotide Synthesis Revenue and Growth Rate (2012-2017)
4.2 Middle East Oligonucleotide Synthesis Sales and Market Share by Type
4.3 Middle East Oligonucleotide Synthesis Sales and Market Share by Application
4.4 Middle East Oligonucleotide Synthesis Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Oligonucleotide Synthesis Sales Volume by Countries (2012-2017)
4.4.2 Middle East Oligonucleotide Synthesis Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
4.4.4 Israel Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
4.4.5 UAE Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
4.4.6 Iran Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
5 Africa Oligonucleotide Synthesis (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Oligonucleotide Synthesis Sales and Value (2012-2017)
5.1.1 Africa Oligonucleotide Synthesis Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Oligonucleotide Synthesis Revenue and Growth Rate (2012-2017)
5.2 Africa Oligonucleotide Synthesis Sales and Market Share by Type
5.3 Africa Oligonucleotide Synthesis Sales and Market Share by Application
5.4 Africa Oligonucleotide Synthesis Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Oligonucleotide Synthesis Sales Volume by Countries (2012-2017)
5.4.2 Africa Oligonucleotide Synthesis Revenue by Countries (2012-2017)
5.4.3 South Africa Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
5.4.5 Egypt Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
5.4.6 Algeria Oligonucleotide Synthesis Sales and Growth Rate (2012-2017)
6 EMEA Oligonucleotide Synthesis Manufacturers/Players Profiles and Sales Data
6.1 Genescript
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Genescript Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 GeneArt (Thermofischer)
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 GeneArt (Thermofischer) Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 IDT
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 IDT Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 DNA 2.0 (ATUM)
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 DNA 2.0 (ATUM) Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 OriGene
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 OriGene Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 BBI
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 BBI Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Genewiz
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Genewiz Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Eurofins Genomics
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Eurofins Genomics Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Gene Oracle
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Gene Oracle Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 SBS Genetech
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Oligonucleotide Synthesis Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 SBS Genetech Oligonucleotide Synthesis Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Bio Basic
7 Oligonucleotide Synthesis Manufacturing Cost Analysis
7.1 Oligonucleotide Synthesis Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oligonucleotide Synthesis
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Oligonucleotide Synthesis Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oligonucleotide Synthesis Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Oligonucleotide Synthesis Market Forecast (2017-2022)
11.1 EMEA Oligonucleotide Synthesis Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Oligonucleotide Synthesis Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Oligonucleotide Synthesis Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Oligonucleotide Synthesis Price and Trend Forecast (2017-2022)
11.2 EMEA Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Oligonucleotide Synthesis Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Oligonucleotide Synthesis Sales Forecast by Type (2017-2022)
11.7 EMEA Oligonucleotide Synthesis Sales Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Similar Reports
Summary Based on products type, the report describes major products type share of regional market. Products mentioned as follows: By Type ?1 KW 1 KW-5 KW Based on region, the report describes major regions market by vendor, products and Application. Regions mentioned as follows: Europe North America China Japan & Korea India Based on Application, the report describes major Application shar...
- Publish Date: April 1, 2017
- $800
The turbine generator market is expected to witness strong growth with government taking favourable initiatives to support the power sector. The report provides a brief overview of the turbine generator market in India, the market size and growth in value and volume terms has been provided. It also includes the market segmentation. An analysis of the drivers reveals that rise in overall power ...
- Publish Date: January 18, 2011
- $950
The natural gas market in India is witnessing growth and capacity expansions to meet the growing demand for gas consumption as a result of growth in industrial, auto and commercial sector. Increased economic activity is providing the players an opportunity for growth and expansion. The report provides a brief introduction to the natural gas industry. The market overview includes information rega...
- Publish Date: July 19, 2011
- $950
